Camizestrant in combination with capivasertib for women with ER-positive, HER2-negative advanced breast cancer: results from SERENA-1
卡美司群联合卡帕替尼治疗ER阳性、HER2阴性晚期乳腺癌女性患者:SERENA-1研究结果
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.106049
Vaklavas, C; Oliveira, M; Armstrong, A C; Moreno, I; Twelves, C; Victoria Ruiz, I; Bermejo de Las Heras, B; Brier, T; Ciardullo, C; Gibbons, L; Jack, T; Klinowska, T; Lindemann, J P O; Mathewson, A M; Maudsley, R; Morrow, C J; Sykes, A; Baird, R D